{"log_id": 7854614782529625209, "direction": 0, "words_result_num": 42, "words_result": [{"probability": {"variance": 0, "average": 0.998892, "min": 0.998264}, "location": {"width": 58, "top": 58, "height": 32, "left": 1091}, "words": "国家"}, {"probability": {"variance": 0, "average": 0.996986, "min": 0.996986}, "location": {"width": 25, "top": 101, "height": 26, "left": 1130}, "words": "药"}, {"probability": {"variance": 0.0001, "average": 0.995781, "min": 0.941538}, "location": {"width": 784, "top": 189, "height": 50, "left": 206}, "words": "血小板减少症、溶血性贫血、造血功能损伤性不良事件(包括再生障碍性贫血、全血细胞减"}, {"probability": {"variance": 0, "average": 0.985393, "min": 0.985393}, "location": {"width": 30, "top": 210, "height": 30, "left": 1101}, "words": "局"}, {"probability": {"variance": 0.001453, "average": 0.991252, "min": 0.755288}, "location": {"width": 784, "top": 228, "height": 51, "left": 207}, "words": "少症、骨髓发育不良和粒细胞缺乏症)和血管炎综合征(例如过敏性紫癜)。在同时服用本"}, {"probability": {"variance": 0.011589, "average": 0.967269, "min": 0.478912}, "location": {"width": 785, "top": 266, "height": 55, "left": 207}, "words": "品和苯妥英4周后,收到1例苯妥英血药浓度升高的报告。还有1例在美洛小长期治疗中"}, {"probability": {"variance": 0.013353, "average": 0.687422, "min": 0.571866}, "location": {"width": 63, "top": 292, "height": 34, "left": 839}, "words": "生约"}, {"probability": {"variance": 0.012924, "average": 0.967934, "min": 0.527859}, "location": {"width": 320, "top": 323, "height": 37, "left": 210}, "words": "加用本品后发生了严重低血压的报告"}, {"probability": {"variance": 0, "average": 0.999283, "min": 0.998795}, "location": {"width": 66, "top": 373, "height": 25, "left": 222}, "words": "【禁忌】"}, {"probability": {"variance": 0, "average": 0.911977, "min": 0.911977}, "location": {"width": 46, "top": 374, "height": 36, "left": 924}, "words": "天"}, {"probability": {"variance": 0, "average": 0.951815, "min": 0.951815}, "location": {"width": 19, "top": 416, "height": 21, "left": 210}, "words": "1"}, {"probability": {"variance": 0.002369, "average": 0.984873, "min": 0.803023}, "location": {"width": 300, "top": 401, "height": 36, "left": 286}, "words": "已知对本品及其赋形剂过敏者禁用"}, {"probability": {"variance": 0.000436, "average": 0.98901, "min": 0.915783}, "location": {"width": 784, "top": 427, "height": 51, "left": 210}, "words": "2.本品禁止与单胺氧化酶抑制剂合用(包括抗生素类药物利奈唑胺,一种可逆,非选择性"}, {"probability": {"variance": 0.006933, "average": 0.974046, "min": 0.575272}, "location": {"width": 784, "top": 467, "height": 51, "left": 213}, "words": "的单胺氧化酶抑制剂)或在以单胺氧化酶抑制剂进行治疗结束后两周内使用。同样,在以本"}, {"probability": {"variance": 0.000217, "average": 0.994814, "min": 0.924095}, "location": {"width": 698, "top": 508, "height": 48, "left": 214}, "words": "品进行治疗结束后两周内亦禁止使用单胺氧化酶抑制剂(详见【药物相互作用】)"}, {"probability": {"variance": 0.013142, "average": 0.963927, "min": 0.398167}, "location": {"width": 784, "top": 544, "height": 51, "left": 215}, "words": "3.本品禁止与甲硫哒嗪合用。因为与其他抑制肝脏细胞色素P450同工酶CYP45026的药"}, {"probability": {"variance": 0.000647, "average": 0.9921, "min": 0.841316}, "location": {"width": 782, "top": 581, "height": 53, "left": 218}, "words": "物一样,本品可引起甲硫哒嗪的血浆浓度升高(见【药物相互作用】)。单独使用甲硫哒嗪可"}, {"probability": {"variance": 0.006561, "average": 0.975956, "min": 0.497254}, "location": {"width": 780, "top": 621, "height": 52, "left": 219}, "words": "导致QTe间期延长,并伴有严重的室性心律不齐,例如心电图表现穗尖现象(波峰扭曲)和猝"}, {"probability": {"variance": 0, "average": 0.999767, "min": 0.999767}, "location": {"width": 23, "top": 688, "height": 23, "left": 221}, "words": "死"}, {"probability": {"variance": 0.001764, "average": 0.943386, "min": 0.901385}, "location": {"width": 19, "top": 729, "height": 18, "left": 221}, "words": "4."}, {"probability": {"variance": 0.017667, "average": 0.926241, "min": 0.643973}, "location": {"width": 190, "top": 717, "height": 31, "left": 297}, "words": "本品禁止与哌迷清(p"}, {"probability": {"variance": 0.008941, "average": 0.968512, "min": 0.592904}, "location": {"width": 328, "top": 704, "height": 37, "left": 532}, "words": "de)合并使用(见【药物相互作用】"}, {"probability": {"variance": 3.6e-05, "average": 0.994206, "min": 0.98428}, "location": {"width": 71, "top": 761, "height": 26, "left": 230}, "words": "【警告】"}, {"probability": {"variance": 0.000515, "average": 0.988004, "min": 0.915258}, "location": {"width": 244, "top": 792, "height": 37, "left": 261}, "words": "1.临床病情恶化和自杀风险"}, {"probability": {"variance": 9.2e-05, "average": 0.995292, "min": 0.967431}, "location": {"width": 202, "top": 834, "height": 32, "left": 265}, "words": "成人或儿童重度抑郁症"}, {"probability": {"variance": 3e-06, "average": 0.99917, "min": 0.991537}, "location": {"width": 474, "top": 817, "height": 40, "left": 533}, "words": "患者无论是否服用抗抑郁药物,都可能会出现抑郁症状"}, {"probability": {"variance": 0.002382, "average": 0.985122, "min": 0.750813}, "location": {"width": 782, "top": 855, "height": 51, "left": 226}, "words": "恶化和/或出现自杀意念和自杀行为(自杀倾向),患病期间这种危险性持续存在,直至病"}, {"probability": {"variance": 3.1e-05, "average": 0.997076, "min": 0.969398}, "location": {"width": 782, "top": 894, "height": 51, "left": 226}, "words": "情得到显著缓解。自杀是抑郁及某些其他精神疾病的一种已知风险,这些疾病本身就是发生"}, {"probability": {"variance": 0.010679, "average": 0.975184, "min": 0.424833}, "location": {"width": 782, "top": 932, "height": 54, "left": 229}, "words": "自杀最强烈的预测因子长期以来一直认为抗抑郁药治疗的早期会诱导某些患者病情恶化和"}, {"probability": {"variance": 0.003706, "average": 0.977809, "min": 0.701295}, "location": {"width": 766, "top": 973, "height": 52, "left": 229}, "words": "出现自杀倾向。抗抑郁药物(选择性5羟色胺再摄取抑制剂(SSRI)类和其他种类)的短期"}, {"probability": {"variance": 8.9e-05, "average": 0.996555, "min": 0.955229}, "location": {"width": 764, "top": 1012, "height": 52, "left": 230}, "words": "安慰剂对照临床试验数据的综合分析显示,在儿童、青少年以及青年患者(18~24岁)中"}, {"probability": {"variance": 0.001074, "average": 0.989225, "min": 0.84928}, "location": {"width": 784, "top": 1050, "height": 51, "left": 231}, "words": "这些药物会增加重度抑郁症和其他精神疾病患者的自杀意念和自杀行为(自杀倾向)。抗抑"}, {"probability": {"variance": 9e-06, "average": 0.99812, "min": 0.985173}, "location": {"width": 781, "top": 1088, "height": 52, "left": 234}, "words": "郁药物的短期临床试验显示,与安慰剂相比较,在24岁以上的成人患者中自杀风险没有升"}, {"probability": {"variance": 0.0023, "average": 0.983165, "min": 0.776321}, "location": {"width": 449, "top": 1136, "height": 42, "left": 235}, "words": "高,在65岁以上的成人患者中自杀风险反而有下降"}, {"probability": {"variance": 0.000467, "average": 0.994307, "min": 0.868041}, "location": {"width": 742, "top": 1165, "height": 50, "left": 277}, "words": "在儿童和青少年重度抑郁症、强迫症或其他精神类疾病的患者中,安慰剂对照临床试验"}, {"probability": {"variance": 0.000333, "average": 0.994856, "min": 0.880171}, "location": {"width": 782, "top": 1204, "height": 52, "left": 238}, "words": "的综合分析资料,包括了9种抗抑郁药物,在4400例患者中进行的24项短期临床试验。在"}, {"probability": {"variance": 0.000443, "average": 0.994364, "min": 0.869637}, "location": {"width": 782, "top": 1242, "height": 54, "left": 239}, "words": "成人重度抑郁症或其他精神类疾病的患者中,安慰剂对照临床试验的综合分析,则包括了"}, {"probability": {"variance": 0.001216, "average": 0.989759, "min": 0.774069}, "location": {"width": 785, "top": 1282, "height": 52, "left": 240}, "words": "11种抗抑郁药物,在超过77000多例患者中进行的295项短期临床试验(中位持续时间为2"}, {"probability": {"variance": 2.2e-05, "average": 0.997435, "min": 0.979633}, "location": {"width": 784, "top": 1321, "height": 51, "left": 242}, "words": "个月)。不同药物之间的自杀风险不同,但几乎所有试验药物在较年轻患者中的自杀风险都"}, {"probability": {"variance": 0.004674, "average": 0.983249, "min": 0.647042}, "location": {"width": 773, "top": 1361, "height": 50, "left": 243}, "words": "有升高的趋势;不同适应症之间的绝对自杀风险也不同的,以重度抑郁症的发生率为最高"}, {"probability": {"variance": 9.5e-05, "average": 0.995748, "min": 0.952981}, "location": {"width": 727, "top": 1398, "height": 52, "left": 295}, "words": "在年龄分层以及各适应症之间的风险差异(药物与安慰剂之间)相对稳定,这些差异"}, {"probability": {"variance": 0.0001, "average": 0.991686, "min": 0.966177}, "location": {"width": 533, "top": 1446, "height": 44, "left": 256}, "words": "详见表1(每1000例治疗患者中自杀例数的药物一安慰剂差异)"}], "language": 3}